These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34185430)

  • 1. Long non-coding RNAs are significantly associated with prognosis and response to therapies in gastric cancer.
    Shin MK; Kim J; Kim D; Lee SH; Shin JH; Jeong YS; Sohn BH; Kim J; Kim SR; Ajani JA; Lee JS; Cheong JH
    Clin Transl Med; 2021 Jun; 11(6):e421. PubMed ID: 34185430
    [No Abstract]   [Full Text] [Related]  

  • 2. LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer.
    Shi XY; Sun YZ; Li M; Li HY
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):232-238. PubMed ID: 31389606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
    Xu Q; Wang Y; Huang W
    Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormally expressed long noncoding RNA B3GALT5-AS1 may serve as a biomarker for the diagnostic and prognostic of gastric cancer.
    Feng W; Zong W; Li Y; Shen X; Cui X; Ju S
    J Cell Biochem; 2020 Jan; 121(1):557-565. PubMed ID: 31338903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the complex regulatory relationships related to gastric cancer from lncRNA-miRNA-mRNA network.
    Wang J; Ding Y; Wu Y; Wang X
    J Cell Biochem; 2020 Jan; 121(1):876-887. PubMed ID: 31452262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.
    Fattahi S; Kosari-Monfared M; Golpour M; Emami Z; Ghasemiyan M; Nouri M; Akhavan-Niaki H
    J Cell Physiol; 2020 Apr; 235(4):3189-3206. PubMed ID: 31595495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression.
    Guo W; Liang X; Liu L; Guo Y; Shen S; Liang J; Dong Z
    Gastric Cancer; 2019 Jul; 22(4):705-722. PubMed ID: 30656427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA ZEB1-AS1 predicts unfavorable prognosis in gastric cancer.
    Li Y; Wen X; Wang L; Sun X; Ma H; Fu Z; Li L
    Surg Oncol; 2017 Dec; 26(4):527-534. PubMed ID: 29113674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Profiling Revealed Potential Regulatory Networks Among Long Noncoding RNAs and mRNAs in Mucosal Gastric Cancer.
    Sun KK; Shen XJ; Yang D; Jiao Y; Wu XY
    Technol Cancer Res Treat; 2020; 19():1533033820930119. PubMed ID: 32468960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression.
    Wang X; Ren M; Li Y; Hu J; Lu G; Ma W; Guo D; Lu X; He S
    J Cell Biochem; 2019 Apr; 120(4):5704-5712. PubMed ID: 30324628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients.
    Yuan Q; Gao C; Lai XD; Chen LY; Lai TB
    Dis Markers; 2020; 2020():8895968. PubMed ID: 33282010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA HOXC-AS1 promotes gastric cancer via binding eIF4AIII by activating Wnt/β-catenin signaling.
    Zhou C; An N; Cao C; Wang G
    J Gene Med; 2020 Sep; 22(9):e3202. PubMed ID: 32307743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance.
    Zhu S; Mao J; Shao Y; Chen F; Zhu X; Xu D; Zhang X; Guo J
    Tumour Biol; 2015 Sep; 36(10):8041-5. PubMed ID: 25971582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance.
    Lin X; Yang M; Xia T; Guo J
    Med Oncol; 2014 Jul; 31(7):42. PubMed ID: 24984296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer.
    Yang Z; Dong X; Pu M; Yang H; Chang W; Ji F; Liu T; Wei C; Zhang X; Qiu X
    Gastric Cancer; 2020 May; 23(3):449-463. PubMed ID: 31673844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs.
    Zhang E; Yin D; Han L; He X; Si X; Chen W; Xia R; Xu T; Gu D; De W; Guo R; Xu Z; Chen J
    Oncotarget; 2016 Apr; 7(17):23212-26. PubMed ID: 27036039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
    Li C; Wu R; Xing Y
    Cell Cycle; 2020 Mar; 19(5):601-609. PubMed ID: 32079456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relationship Between ZEB1-AS1 Expression and the Prognosis of Patients With Advanced Gastric Cancer Receiving Chemotherapy.
    Chai H; Sun C; Liu J; Sheng H; Zhao R; Feng Z
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819849069. PubMed ID: 31072267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.